Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications are described as automatically filled from PubMed with an updated Revision: v3.3.2. The previous note about PubMed publications and Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check28 days agoChange Detected- Removed the banner notice about government funding and NIH Clinical Center operating status; the page no longer displays that status information.SummaryDifference0.2%

- Check43 days agoChange DetectedThe POLO study page content remains unchanged between the two screenshots. Core sections such as the title, study design, eligibility criteria, outcomes, and listed locations are the same.SummaryDifference0.2%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedAdds a new version label (v3.1.0) and removes multiple drug-related topics, indicating a restructuring and potential narrowing of content.SummaryDifference0.3%

- Check93 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.